Skip to main content

Peer Review reports

From: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

Original Submission
20 Jun 2023 Submitted Original manuscript
15 Oct 2023 Reviewed Reviewer Report - crispin musicha
19 Oct 2023 Reviewed Reviewer Report - Lexy Sorrell
23 Nov 2023 Author responded Author comments - Simron Singh
Resubmission - Version 2
23 Nov 2023 Submitted Manuscript version 2
24 Nov 2023 Editorially accepted
16 Jan 2024 Article published 10.1186/s13063-023-07834-8

You can find further information about peer review here.

Back to article page